Jeremy Richards is the Manager/Director of a private wealth fund. He has twenty years investment expertise. He left Wall Street and is much happier on Main Street.
*What the mind can conceive and believe it can achieve. Napoleon Hill
*The difference between who you are today and who you will be in 5 years is the people you spend time with and the books you read.
*Most people get ahead during the time others waste.
I am an advocate of the acquisition of wisdom (the ability to recognize difference) and being a constant learning machine. We were born into this world ignorant and incoherent and this mental capacity can only be remedied by obtaining wisdom and knowledge vicariously through others or by experience. I prefer both. Modeling is a very effective mental model and overcomes the learning curve of a discipline at an escalating rate. Warren Buffett / John Maynard Keynes / Peter Lynch are the models I use. Inventing the wheel contributes to loss in opportunity costs, inadequacy of conviction in ones conclusions, lack of direction, shortage of confidence to concentrate assets (not over diversifying) and steep expensive learning curves.
Awareness does not bring success. Implementation of awareness develops results, and it is refined results persistently applied that attracts a fortune. A fortune can't be pursued it must be attracted through a definite purpose, definite plan put into continuous action, and concentration of effort that is persevered through all possible tempting distractions.
All is well because all grows better.
Currently Vice President of Business Development dedicated to the discovery and creation of shareholder value for Life Science companies.
--Extensive Scientific Research experience in Pharmaceutical and Medical Device Companies AMGEN, ALLERGAN
--Experience as Technical Liaison/Advisor for prominent financial institutions focused on Healthcare and Biotech investments
Prior experience includes:
AMGEN: (Research Scientist ) Drug Product Process Development, Drug Engineering, FDA technology- liaison, Product Characterization, Commercial Manufacturing Support, Commercial Drug Development , Drug Formulation and Pre-commercial Drug Product Tech Transfer.
ALLERGAN: (Research Scientist) Project design and management of proprietary materials and data for medical device and medical aesthetic products. Scientific research team lead of collagen and capsular-contracture studies for devices. Biomaterial optimization applying advanced histology, cell culture and immunohistochemistry.
OPUS Point Partners/OPN Capital Markets/ National Securities: Scientific Advisor and technology liaison. Worked alongside lead market strategist and lead biotech analyst at National Securities for The Biotech Group. Lead the due diligence process for the Managing Director at OPN Capital Markets, reviewing product mechanisms,intellectual property and overall technology/concept viability.
I have around eleven years of finance experience, of which six were gained in a ‘fast-stream’ career path as a bottom-up fundamental analyst with highly regarded investors. My most recent role was as an investment consultant with a former partner at one of London's most successful hedge-funds and we were looking to launch a new fund together. Before that, I was the senior analyst at a Goldman Sachs spin-out fund seeded by a top 50 hedge-fund of funds. I'm ready to step up to a position as a PM but am very open to positions as an analyst. I started my career in corporate finance and was a Goldman Sachs summer intern. I also have experience as a quant in the systematic equity investment space. I am passionate about investing and I come with excellent references from impressive individuals; I am now seeking my next challenge.
Farah Merchant, Capital Markets Advisor, Proactive Capital Group
ProActive Capital Group, LLC (“PCG”) is dedicated to the discovery and creation of shareholder value for public companies. PCG has specific experience with life science, high technology and international companies.
PCG provides its clients with capital market advisory, strategic communication and multimedia marketing services. We adapt these services to each client’s particular needs to successfully reach and influence key capital market participants in order to maximize shareholder value.
PCG’s capital market advisory services include overall investor strategy development to increase and leverage investor awareness, visibility & credibility.
PCG’s strategic communications services leverage digital media channels to further increase awareness to all key constituents.
PCG’s multimedia marketing services include direct mail, email marketing, investor presentation production, video production and website development
Capital Markets consultant and active investor in the emerging life science space. Tenured futures trader. Able to provide access to a pool of investors and traders throughout the US and UK. ProActive Capital, a capital markets advisory firm that makes direct investments and provides advisory services into public and private life science companies. Areas of focus include; capital introduction, shareholder management, communications and investor outreach.